CN102742706A - Metasilicic acid tea bag capable of preventing cardiovascular disease - Google Patents
Metasilicic acid tea bag capable of preventing cardiovascular disease Download PDFInfo
- Publication number
- CN102742706A CN102742706A CN2012102602571A CN201210260257A CN102742706A CN 102742706 A CN102742706 A CN 102742706A CN 2012102602571 A CN2012102602571 A CN 2012102602571A CN 201210260257 A CN201210260257 A CN 201210260257A CN 102742706 A CN102742706 A CN 102742706A
- Authority
- CN
- China
- Prior art keywords
- metasilicic acid
- tea bag
- bag
- tea
- cardiovascular disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention aims to provide a metasilicic acid tea bag capable of preventing cardiovascular disease. The metasilicic acid tea bag comprises the following components in percentage by weight: 66.43-76.43 percent of metasilicic acid particles, 12.86-22.86 percent of chitosan and 7.71-13.71 percent of edible mint, lemon or jasmine. The components are mixed and then packaged into the tea bag through a filter bag. The tea bag has the beneficial effect that the metasilicic acid trace element is effectively replenished for a human body in the form of tea. Thus, the aims of preventing and treating atherosclerotic plaque form and softening blood vessels are fulfilled.
Description
Technical field
The present invention relates to a kind of can Prevention of Cardiovascular sick metasilicic acid tea in bag, belong to field of beverage.
Background technology
Angiocardiopathy such as hypertension, coronary heart disease, the angiosclerotic death rate is increasingly high, becomes the mat woven of fine bamboo strips one healthy killer.The various troche of health products of relevant angiocardiopathy preventing, medicament, glue are assisted domestic plentifully, the international market.To satisfy patient demand.
Yet; By the generally acknowledged metasilicic acid softening blood vessel special efficacy of international medical community; But do not receive common concern; Main cause is that metasilicic acid to still there not being artificial exploitation so far, does not particularly still meet the tendency this technological achievement in the daily life tea in bag form that the common people like inter alia.
Summary of the invention
The purpose of this invention is to provide a kind of can Prevention of Cardiovascular sick metasilicic acid tea in bag, comprise following component, each component by weight content is:
(1) metasilicic acid particle 66.43-76.43%;
(2) chitosan 12.86-22.86%;
(3) edible peppermint, or lemon, or jasmine 7.71-13.71%;
Above-mentioned prescription is mixed the back be packaged into tea in bag with filter bag.
The beneficial effects of the present invention to form partial silicon fermentation tea on the human body trace elements for effective supplement.To reach anti-smelting arteries AP form, softening blood vessel purpose.
Silicon partial fermentation (H
2 SiO
3 ) is the national accreditation standards mineral nine trace elements in a.The metasilicic acid element mainly is distributed in people's the skin and connective tissue, and it has the recovery blood vessel elasticity, removes the effect of blood vessel deposition fat.Therefore.The protection cardiovascular and cerebrovascular yarn normal function of uniting is that the metasilicic acid master plays effect.Cause cardiovascular and cerebrovascular generation pathology to prevent to lack the metasilicic acid element in the human body.Produce arterial sclerosis.Diseases such as coronary heart disease.The metasilicic acid beneficial element is prone to be absorbed by the body simultaneously, effectively keeps human body dielectric balance and physiological function, promotes the bone growth altar to add the elasticity and the intensity of cartilage connective tissue.
The specific embodiment
Each component of the present invention by weight content is:
Metasilicic acid particle 71.43%; Select 2 grams for use for every bag;
Chitosan 17.86%; Select 0.5 gram for use for every bag;
Edible peppermint, or lemon, or jasmine 10.71%; Select 0.3 gram for use for every bag;
Above-mentioned prescription is mixed the back be packaged into tea in bag, use the boiling water Instant Drinks with filter bag.
Claims (1)
1. the metasilicic acid tea in bag that Prevention of Cardiovascular is sick comprises following component, and each component by weight content is:
(1) metasilicic acid particle 66.43-76.43%;
(2) chitosan 12.86-22.86%;
(3) edible peppermint, or lemon, or jasmine 7.71-13.71%;
Above-mentioned prescription is mixed the back be packaged into tea in bag with filter bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102602571A CN102742706A (en) | 2012-07-26 | 2012-07-26 | Metasilicic acid tea bag capable of preventing cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102602571A CN102742706A (en) | 2012-07-26 | 2012-07-26 | Metasilicic acid tea bag capable of preventing cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102742706A true CN102742706A (en) | 2012-10-24 |
Family
ID=47023481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102602571A Pending CN102742706A (en) | 2012-07-26 | 2012-07-26 | Metasilicic acid tea bag capable of preventing cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102742706A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062827A (en) * | 1991-11-13 | 1992-07-22 | 韶关市饮料厂 | The production method of mineral wulong tea drink |
| CN101366423A (en) * | 2008-10-08 | 2009-02-18 | 许子良 | Natural tea for protecting liver, relieving or neutralizing the effect of alcohol |
| WO2011008028A2 (en) * | 2009-07-14 | 2011-01-20 | 주식회사 메자이텍 | Functional drinking water for improving blood circulation, and method for preparing same |
-
2012
- 2012-07-26 CN CN2012102602571A patent/CN102742706A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062827A (en) * | 1991-11-13 | 1992-07-22 | 韶关市饮料厂 | The production method of mineral wulong tea drink |
| CN101366423A (en) * | 2008-10-08 | 2009-02-18 | 许子良 | Natural tea for protecting liver, relieving or neutralizing the effect of alcohol |
| WO2011008028A2 (en) * | 2009-07-14 | 2011-01-20 | 주식회사 메자이텍 | Functional drinking water for improving blood circulation, and method for preparing same |
Non-Patent Citations (4)
| Title |
|---|
| 刘玲等: "克东县二克山地区偏硅酸矿泉水特征及形成机制分析", 《黑龙江科技信息》 * |
| 姬小明等: "甲壳素/壳聚糖及其衍生物在食品工业中的应用新进展", 《平原大学学报》 * |
| 李光祥等: "马坡矿泉水疗效初析", 《广西地质》 * |
| 莫慧平: "《饮料生产技术》", 31 January 2001 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102550757A (en) | Health-care tea | |
| CN101011496A (en) | Tea for activating blood circulation and removing stasis | |
| CN102293430A (en) | Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof | |
| CN101744072A (en) | Astragalus health tea | |
| CN103478327B (en) | A kind of tea beverage with anti-radiation effect | |
| CN102771607A (en) | Herbal tea capable of eliminating excess fire and preparation method of herbal tea | |
| CN106721853A (en) | A kind of Cordyceps militaris solid beverage composition and preparation method thereof | |
| CN101108227A (en) | Konjak extractive powder capsule | |
| CN103783601A (en) | Relaxed health beverage and preparation method thereof | |
| CN101755970A (en) | Blood pressure lowering health care tea | |
| CN103988937A (en) | Blueberry and honey-containing powdered tea and processing method thereof | |
| CN103082272B (en) | Preparation method of acid-pickled needle mushroom with functions of clearing away heat and toxic materials | |
| CN102805111A (en) | Plant medicament for preventing and treating mustard aphids | |
| CN102742706A (en) | Metasilicic acid tea bag capable of preventing cardiovascular disease | |
| CN1177001A (en) | Multi-functional medicated wine | |
| CN101683164B (en) | Method for manufacturing radiation resistant health drink | |
| CN104106826B (en) | A kind of gadol beverage and preparation method thereof | |
| CN103798880A (en) | Oyster mushroom/lalang grass rhizome compound beverage and preparation method thereof | |
| CN1278616C (en) | Healthy edible oil with coenzyme Q10 | |
| CN103005415A (en) | Blood-fat-reducing herbal cuisine gruel and making method thereof | |
| CN101288689A (en) | Orally-taken traditional Chinese medicines for treating light headedness | |
| CN102018245A (en) | Formula of pig bone soup with fig and preparation method thereof | |
| CN105876406A (en) | Production method of cordyceps militaris oral liquid | |
| CN101697763A (en) | Heat clearing and tranquillizing healthy tea for middle-aged and elderly people | |
| CN1647667A (en) | Longan and chrysanthemum tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121024 |